• Issi R Vedder, Stef Levolger, DierckxRudi A J ORAJODepartment of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Nuclear Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherland, Alain R Viddeleer, and BokkersReinoud P HRPHDepartment of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: r.p.h.bokkers@umcg.nl..
• Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
• Nutrition. 2024 Oct 1; 126: 112492112492.

ObjectivesSignificant variability exists in the contrast phases applied during computed tomography (CT) studies when assessing morphometric measurements of muscle area (CT-assessed sarcopenia) and density (CT-assessed myosteatosis) and visceral adipose tissue area (CT-assessed visceral obesity). This study explored the impact of contrast phase timing on changes in morphometric measurements of body composition.MethodsThis single-center retrospective cohort study included 459 patients undergoing a multiphase CT scan. Morphometric measurements were obtained at the third lumbar vertebra level. Patients were classified as sarcopenic, myosteatotic, or visceral obese using predefined cutoff values. The intraclass correlation coefficient was used to assess correlations across different enhancement phases, and Cohen's κ measured the inter-enhancement agreement for sarcopenia, myosteatosis, and visceral obesity.ResultsSignificant differences were observed in mean visceral adipose tissue area, muscle density, and muscle area (P < 0.001). The intraclass correlation coefficient between unenhanced and arterial phases was 0.987 (95% confidence interval [CI], 0.759-0.996) for adipose tissue, 0.995 (95% CI, 0.989-0.997) for muscle area, and 0.850 (95% CI, 0.000-0.956) for muscle density. However, when morphometric measurements were categorized using predefined cutoffs, the κ agreement was considerably lower, particularly for CT-assessed myosteatosis, ranging from 0.635 (unenhanced to arterial) to 0.331 (unenhanced to late venous phase).ConclusionsDifferent CT contrast phases induce small but clinically significant alterations in the measurements of muscle area and density and visceral fat. Such minor changes can result in misclassification issues when fixed cutoff values are used to diagnose myosteatosis with CT. This underscores the importance of reporting absolute values and the specific contrast phase used in future studies.Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

29 keywords...

hide…